Functional Genomics in Norway (FUGE), which was established in 2002 to build a knowledge base and infrastructure that would help Norway to work at the frontiers of functional genomics research has announced a budget of NOK 920 million ($154.4 million) for 2007–2011, of which NOK 420 million ($70.5 million) is now available for funding projects. […]
According to data compiled in a 2006 study by the Confederation of the Food and Drink Industries of the EU (CIAA), the food and beverage industry was the largest manufacturing sector in the EU in 2005. Its sales grew 2.6% to €836 billion ($1.2 trillion) to represent 13.6% of EU manufacturing sales. In 2005, the […]
Sequenom and QIAGEN GmbH entered into a strategic collaboration to jointly develop a preanalytical solution for small molecule (fetal) DNA enrichment for prenatal diagnostics. Sequenom will retain exclusive distribution rights to the technology for enriching short nucleic acids. In February, Sequenom named Steven Owings to the newly created position of vice president of Commercial Development, […]
The Chinese government has announced a far-reaching, 15-year program to modernize traditional Chinese medicine (TCM). Already, the Chinese government has allotted CNY 1 billion ($130 million) for TCM R&D, and the total budget over the next five years is expected to range between CNY 3.7 billion and CNY 4.4 billion. This new program, which is […]
The equity market continues to find bullish sentiment within a sluggish economy. On April 25, led by a strong rally in the blue chip sector, the Dow surpassed the elusive 13,000 mark for the first time. Exuberance over positive earnings in the technology sector and acquisition news helped push all major indexes higher. For the […]
Following up on IBO’s examination of manufacturing trends in the industry (see IBO 3/31/07), Singapore continues to be a popular location for manufacturing facilities. This February, Fluidigm launched a Biomedical Product Development Center in Singapore, which will be used for R&D of a new biochip fluorescence reader and biochip loader. Bio-Rad unveiled a 20,000 square […]
Chalfont St. Giles, England 4/16/07—GE Healthcare has acquired Wave Biotech, a supplier of disposable manufacturing technologies, including the Wave bioreactor, Wave Mixer and Sterile Tube Fuser. Financial details were not disclosed. Based in Somerset, New Jersey, with approximately 70 employees, Wave Biotech has annual revenues of $25 million and its equipment is used at over […]
CyBio AG’s 2006 revenues grew 8.2% to €15.5 million ($20.6 million). North American sales increased 18.0% to make up 45.4% of revenues, European sales rose 2.4% to represent 49.7% and Asian sales declined to 4.9% of revenues. Germany accounted for 21.6% of total sales. The instrument business accounted for approximately half of company revenues. In […]
Canada plans to spend CAD 9.2 billion ($8.0 billion) on science and technology in 2007–08. University laboratories received a CAD 510 million ($443.1 million) disbursement for purchasing new scientific equipment and CAD 15 million ($13.0 million) to cover “indirect” research costs. The three councils in Canada that give research grants each had their budgets boosted […]
According to David Bannon, COO and cofounder of Headwall Photonics, the headwall is usually the most difficult part of a mountain climb. It is from this willingness to take on difficult technological challenges, as well as the need for cooperation that climbing entails, that Headwall Photonics takes its name. The company’s prospects have been rising […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
